StockData
Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc. (REGN) stock

REGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 16/308% above fair value
$951.19−8.22 (-0.86%)

Close on Nov 12, 2026Market cap $98.40BP/E 21.0Yield –

Regeneron Pharmaceuticals statistics

106 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Jan 29, 2027 (estimated, before the open)
Last ex-dividend date
Nov 20, 2026
Fundamentals through
Sep 30, 2026
Share price as of
Nov 12, 2026

Valuation ratiosIndustry

Market Cap
$98.40B
$280.48M
Enterprise Value
$91.08B
$148.62M
PE Ratio
21.01
24.95
PS Ratio
5.82
3.60
PB Ratio
2.94
2.05
P/TBV Ratio
3.06
2.29
P/FCF Ratio
25.72
18.26
P/OCF Ratio
20.31
12.93

Enterprise valuationIndustry

EV / Sales
5.39
2.60
EV / EBITDA
16.94
16.52
EV / EBIT
18.72
18.72
EV / FCF
23.80
22.07

Share statisticsIndustry

Shares Outstanding
103M
58M
Shares Change (YoY)
-3.09%
10.9%
Float
100M
49M
Shares Held by Insiders
3.74%
12.1%
Shares Held by Institutions
88.5%
56.4%

Short sellingIndustry

Short Interest
2M
–
Short Interest Change
3.85%
-0.76%
Short % of Float
2.23%
9.06%
Short % of Shares Outstanding
2.14%
6.30%
Days to Cover
2.73
5.13

Stock price statisticsIndustry

52-Week High
$991.73
–
52-Week Low
$591.52
–
20-Day Moving Average
$870.64
–
50-Day Moving Average
$813.93
–
200-Day Moving Average
$745.87
–
Average True Range (14)
$32.87
–
Price Change (1 Week)
5.35%
1.51%
Price Change (1 Month)
22.2%
-2.37%
Price Change (3 Months)
18.4%
-21.1%
Price Change (6 Months)
33.4%
-22.8%
Price Change (YTD)
23.2%
-22.6%
Price Change (1 Year)
41.0%
-21.0%
Price Change (3 Years)
19.4%
-24.8%
Price Change (5 Years)
50.7%
-76.9%
Price Change (10 Years)
126.6%
-63.2%
Average Volume (10 Days)
1M
–
Average Volume (20 Days)
984,019
–
Average Volume (90 Days)
787,976
–
Relative Volume
1.55
0.80
Relative Strength Index (14)
67.8
44.7
Volatility (1 Year)
34.1%
80.2%
Beta (5 Years)
0.62
1.07

MarginsIndustry

Operating Margin
28.8%
-38.5%
Pretax Margin
33.7%
-11.8%
Profit Margin
28.5%
-31.7%
EBITDA Margin
31.8%
-27.7%
FCF Margin
22.6%
-8.85%

Returns on capitalIndustry

Return on Equity (ROE)
14.9%
-51.3%
Return on Assets (ROA)
11.4%
-40.7%
Return on Invested Capital (ROIC)
16.3%
-32.9%
Return on Capital Employed (ROCE)
12.7%
-38.1%

Financial positionIndustry

Current Ratio
3.35
3.31
Quick Ratio
2.72
2.41
Debt / Equity
0.06
0.50
Debt / EBITDA
0.37
3.15
Debt / FCF
0.52
4.68
Net Debt / EBITDA
-1.36
1.97
Interest Coverage
104.17
-6.35

GrowthIndustry

Revenue Growth (YoY)
18.6%
7.26%
Net Income Growth (YoY)
5.23%
-14.4%
EPS Growth (YoY)
8.35%
-11.7%
FCF Growth (YoY)
-9.37%
7.48%
Revenue Growth (3Y CAGR)
5.62%
2.25%
Revenue Growth (5Y CAGR)
11.0%
6.41%
EPS Growth (3Y CAGR)
2.77%
-0.17%
EPS Growth (5Y CAGR)
6.33%
3.77%

EfficiencyIndustry

Asset Turnover
0.40
0.40
Revenue Per Employee
$1.10M
$429.38K
Profits Per Employee
$312.62K
-$683.67K
Employee Count
15,410
75
WACC
7.92%
10.0%

Income statement (TTM)Industry

Revenue
$16.90B
$66.69M
Operating Income
$4.86B
-$20.99M
Pretax Income
$5.69B
-$13.23M
Net Income
$4.82B
-$21.61M
EBITDA
$5.38B
-$16.85M
EPS (Diluted)
$45.27
-$0.75

Balance sheetIndustry

Cash & Short-Term Investments
$9.30B
$67.18M
Total Debt
$1.99B
$116.91M
Net Cash (Debt)
$7.31B
$16.98M
Net Cash Per Share
$70.70
$0.72
Equity (Book Value)
$33.50B
$52.68M
Book Value Per Share
$323.82
$1.50
Tangible Book Value
$32.18B
$26.74M
Working Capital
$14.59B
$78.52M

Cash flow (TTM)Industry

Operating Cash Flow
$4.85B
-$12.27M
Capital Expenditures
-$1.02B
-$944.00K
Free Cash Flow
$3.83B
-$18.20M
FCF Per Share
$36.99
-$0.42

Dividends and yieldsIndustry

Earnings Yield
4.90%
-21.0%
FCF Yield
3.89%
-9.44%
Buyback Yield
2.05%
-0.73%
Shareholder Yield
2.05%
0.00%
Payout Ratio
7.95%
55.4%
FCF Payout Ratio
10.0%
44.4%

Taxes and interestIndustry

Interest Expense
$46.70M
$2.97M
Income Tax
$869.40M
$74.00K
Effective Tax Rate
15.3%
20.9%

Scores and fair valueIndustry

Graham Number
$574.31
$19.34
Graham Upside
-39.6%
-46.3%
Altman Z-Score
7.79
0.26
Piotroski F-Score
5
4
Lynch Fair Value
$286.50
–
Lynch Upside
-69.9%
-28.1%

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodREGNS&P 500DifferenceREGN per yearS&P 500 per year
1 month+24.7%-2.7%+27.4 pts
3 months+19.3%-1.7%+21.1 pts
Year to date+23.7%+11.9%+11.8 pts
1 year+40.2%+12.0%+28.3 pts
3 years+20.2%+78.2%−58.0 pts+6.3%+21.2%
5 years+52.1%+73.2%−21.1 pts+8.8%+11.6%
10 years+128.7%+309.6%−180.9 pts+8.6%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

2M REGN shares were sold short on Oct 30, 2026, up 3.8% from the previous report, or 2.23% of the shares available to trade. At recent volumes it would take 2.7 days to buy them back. Over the last 20 sessions, 47.3% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20262,217,114+3.8%810,8502.7
Oct 15, 20262,134,934-0.7%670,7143.2
Sep 30, 20262,150,303-14.9%863,8422.5
Sep 15, 20262,526,446-1.0%571,2714.4
Aug 31, 20262,552,029+6.5%662,8643.9
Aug 14, 20262,396,152-29.2%760,6543.1
Jul 31, 20263,385,841-3.3%858,6623.9
Jul 15, 20263,501,203+0.2%741,2244.7
Jun 30, 20263,494,420+5.8%1,199,8402.9
Jun 15, 20263,304,329+10.1%968,6903.4
May 29, 20263,001,968+8.0%1,532,4322.0
May 15, 20262,780,809-15.0%764,0413.6

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?